Cargando…

Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions

BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives...

Descripción completa

Detalles Bibliográficos
Autores principales: Elfassy, Caroline, Wagner, Lisa, Higgins, Johanne, Montpetit, Kathleen, Snider, Laurie, Dahan-Oliel, Noémi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408044/
https://www.ncbi.nlm.nih.gov/pubmed/37553603
http://dx.doi.org/10.1186/s40900-023-00479-6
_version_ 1785086097231970304
author Elfassy, Caroline
Wagner, Lisa
Higgins, Johanne
Montpetit, Kathleen
Snider, Laurie
Dahan-Oliel, Noémi
author_facet Elfassy, Caroline
Wagner, Lisa
Higgins, Johanne
Montpetit, Kathleen
Snider, Laurie
Dahan-Oliel, Noémi
author_sort Elfassy, Caroline
collection PubMed
description BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives and involvement is a crucial and necessary step. This study sought to determine the most clinically useful items for an outcome measure of UE function for children with AMC as defined by caregivers and clinicians. METHODS: To ensure the perspectives and needs of caregivers of children with AMC and clinicians were considered in the development of the UE measure for AMC, a Nominal Group technique (NGT) with caregivers of children with AMC (phase 1) followed by a three-round survey with clinicians (phase 2) were carried out. RESULTS: Phase 1: Eleven individuals participated in the nominal group technique and identified 32 items. The most important items were Picking up an object (n = 11), Eating (n = 10), Reaching mouth (n = 10), Getting out of bed (n = 10). Phase 2: Invitations to participate to an online survey was sent to 47 experts in the field of AMC, 20 participants completed round 1, 15 completed round 2 and 13 completed round 3. Throughout the survey, participants were asked about movement required to screen the UE, essential domains to be included in the measure, establishing a scoring guide and identifying tasks associated with joint motion and position. CONCLUSION: A preliminary version of an UE AMC-specific outcome measure was developed with the help of caregivers’ perspectives and expert opinions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00479-6.
format Online
Article
Text
id pubmed-10408044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104080442023-08-09 Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions Elfassy, Caroline Wagner, Lisa Higgins, Johanne Montpetit, Kathleen Snider, Laurie Dahan-Oliel, Noémi Res Involv Engagem Research BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives and involvement is a crucial and necessary step. This study sought to determine the most clinically useful items for an outcome measure of UE function for children with AMC as defined by caregivers and clinicians. METHODS: To ensure the perspectives and needs of caregivers of children with AMC and clinicians were considered in the development of the UE measure for AMC, a Nominal Group technique (NGT) with caregivers of children with AMC (phase 1) followed by a three-round survey with clinicians (phase 2) were carried out. RESULTS: Phase 1: Eleven individuals participated in the nominal group technique and identified 32 items. The most important items were Picking up an object (n = 11), Eating (n = 10), Reaching mouth (n = 10), Getting out of bed (n = 10). Phase 2: Invitations to participate to an online survey was sent to 47 experts in the field of AMC, 20 participants completed round 1, 15 completed round 2 and 13 completed round 3. Throughout the survey, participants were asked about movement required to screen the UE, essential domains to be included in the measure, establishing a scoring guide and identifying tasks associated with joint motion and position. CONCLUSION: A preliminary version of an UE AMC-specific outcome measure was developed with the help of caregivers’ perspectives and expert opinions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00479-6. BioMed Central 2023-08-08 /pmc/articles/PMC10408044/ /pubmed/37553603 http://dx.doi.org/10.1186/s40900-023-00479-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Elfassy, Caroline
Wagner, Lisa
Higgins, Johanne
Montpetit, Kathleen
Snider, Laurie
Dahan-Oliel, Noémi
Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
title Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
title_full Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
title_fullStr Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
title_full_unstemmed Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
title_short Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
title_sort stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408044/
https://www.ncbi.nlm.nih.gov/pubmed/37553603
http://dx.doi.org/10.1186/s40900-023-00479-6
work_keys_str_mv AT elfassycaroline stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions
AT wagnerlisa stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions
AT higginsjohanne stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions
AT montpetitkathleen stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions
AT sniderlaurie stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions
AT dahanolielnoemi stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions